Dilikoglu ResearchIDEAS. ANALYSIS. PERSPECTIVE.
← All reports
Nebius Group · NBIS

Nebius Group — Initiation of Coverage

Published · Dilikoglu Research

Page updated 2026-09-25. Publication-date valuation snapshot retained.

Company / ticker
Nebius Group / NBIS
Recommendation
BUY · High risk
Price target
$265 USD · 12–18 months
Reference price
$223.54
Reference date
2026-09-18
Implied upside to target
18.5%

Base intrinsic value of $265.43, rounded to the nearest $5. This is a Base-case realization target, not an expected-return target. Probability-weighted value is $215.89, below the $223.54 report reference; BUY does not imply positive probability-weighted upside. Dated reference, not a live quote.

Executive summary

We initiate NBIS with a BUY · High risk recommendation and a $265 target, based on $265.43 Base intrinsic value. This implies 18.5% upside to the 18 September 2026 closing reference of $223.54. Probability-weighted value remains $215.89 and the Monte Carlo median is $187.76; the report retains the model’s financing and source-verification limitations.

Key investment thesis

  • Base assumes 1,233 MW of incremental 2027 commercial capacity at $20m of new-cohort ARR per MW, yielding $32.664bn exit ARR. These are DR estimates.
  • Customer prepayments and secured financing support growth, but Base still requires $7.058bn of common equity at an assumed $225 issuance price.
  • The $265 target uses Base valuation, not probability-weighted value. The 18 September reference is not a current quote; downside scenarios and source limitations remain material.

Target and rating methodology

Report-specific analyst judgment over 12–18 months against the frozen report reference. No universal numeric BUY/HOLD/SELL thresholds were documented in the finalized research; model upside alone does not assign a recommendation.

Scenario valuation at publication

Model effective 2026-09-13. Frozen publication snapshot; USD per share. Subsequent model updates appear on the Coverage page.

ScenarioProbabilityFair value
Failure10%$0.00
Bear30%$44.24
Base45%$265.43
Bull15%$554.48

Probability-weighted fair value: $215.89. This is separate from the report target.

Key operating assumptions

2027 commercial additions
1,233 MW · DR estimate
New-cohort ARR per MW
$20m · DR estimate
YE27 exit ARR
$32.664bn · DR estimate
FY27 adjusted EBITDA margin
50% · DR estimate
Residual common-equity funding
$7.058bn · DR estimate
AI-cloud valuation
4.0× exit ARR · DR estimate

Primary catalysts

  • >1,000MW annual deployment guidance; comparable new-contract economics

Principal risks and thesis breakers

  • New-cohort pricing or deployment may fall below the underwriting bands.
  • Customer cancellation, default or refund demands could weaken the funding bridge.
  • Secured financing may not repeat at the assumed scale, increasing distressed dilution.

New-cohort yield persistently below $12–15m/MW, deployment below ~700MW, or distressed financing

Current evidence review and open items →

Report-specific conflicts disclosure

At publication of this report, Tugay Dilikoğlu held no NBIS securities and had no material interests in the company. He received no compensation from the company or any third party for this research.

View full report (PDF)

Research updates

Free email updates when we publish new reports or substantive research changes. No fixed sending schedule; unsubscribe at any time.

If the form does not load, use the signup link below.

Subscribe free →

Sign up through Beehiiv and confirm your email address to join. Beehiiv manages your subscription and unsubscribe options. Questions? research@dilikogluresearch.com.